サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1780283

処方薬の市場規模および予測 2021～2031年、世界および地域シェア、動向、成長機会分析レポート：製品タイプ、薬剤タイプ、治療領域、投与経路、流通チャネル、地域

Prescription Drugs Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type, Drug Type, Therapeutic Area, Route Of Administration, Distribution Channel, and Geography

出版日
ページ情報
英文 329 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
処方薬の市場規模および予測 2021～2031年、世界および地域シェア、動向、成長機会分析レポート：製品タイプ、薬剤タイプ、治療領域、投与経路、流通チャネル、地域
出版日: 2025年07月07日
発行: The Insight Partners
ページ情報: 英文 329 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

弊社の最新調査レポート「処方薬市場の2031年までの予測 - 世界分析：製品タイプ別、薬剤タイプ別、投与経路別、治療領域別、流通チャネル別」によると、同市場は2024年の1兆4,407億9,000万米ドルから成長し、2031年には2兆3,501億2,000万米ドルに達すると予測され、2025年から2031年にかけてCAGR 7.3%を記録すると予測されています。処方薬市場の成長は、慢性疾患の蔓延と革新的かつ特殊な医薬品の開発・採用の増加に起因しています。

処方薬とは、法律上、資格を持つヘルスケア専門家による医療用処方箋が必要な医薬品です。身体に重大な影響を及ぼしたり、安全性の監視が必要だったり、誤用の可能性があったりするため、規制されています。

北米の処方薬市場は、米国、カナダ、メキシコに区分されます。北米は世界市場で大きなシェアを占めると思われます。その主な要因のひとつは、同地域の高齢化です。ベビーブーマー世代が高齢化するにつれ、糖尿病、心血管障害、がんなどの慢性疾患の有病率が上昇し、処方薬の需要を押し上げています。

製薬研究とバイオテクノロジーの進歩も重要な役割を果たしています。生物製剤や個別化医療を含む医薬品開発の革新は、治療の選択肢を広げ、有効性と安全性を向上させました。以前は治療不可能だった疾患に対する新規治療法の導入は、市場の成長をさらに後押ししています。

また、医療施設、保険、医薬品流通網への多額の投資に支えられた北米の強力なヘルスケア・インフラも大きな貢献要因となっています。ヘルスケアサービスの普及と疾病管理に対する患者の意識の向上が、処方薬の消費を増加させています。さらに、米国食品医薬品局（FDA）などの規制当局の支援により、革新的な医薬品の迅速な承認プロセスが促進され、迅速な市場参入が可能となっています。さらに、米国の「医療費負担適正化法（Affordable Care Act）」のようなヘルスケア適用範囲の拡大を目指す政府の取り組みにより、より幅広い人々の処方薬へのアクセスが増加しています。

また、生活習慣病の増加や精神疾患の有病率の増加は、治療薬に対する持続的な需要を生み出しています。COVID-19の大流行も医薬品介入の重要性を強調し、医薬品開発と流通への投資を加速させました。

北米では、米国が処方薬市場で大きなシェアを占めています。がん、心臓病、糖尿病などの慢性疾患が処方薬需要の増加に寄与しています。心臓病は依然として米国の主要な死因であり、毎年100万人近くの米国人が心血管疾患（CVD）で死亡しています。米国心臓協会によると、米国では成人の約半数が何らかのCVDに罹患しており、2035年までに心不全を患う成人の数が増加すると予測されています。2035年までに1億3,000万人以上の成人、すなわち米国人口の45.1％が何らかのCVDを訴えると予想されています。このようなCVD患者の急増は、スタチン、β遮断薬、抗凝固薬、降圧薬などの長期投薬管理を必要とする患者の増加につながります。

米国がん協会によると、2022年には国内で新たに190万人ががんと診断され、61万人が死亡しました。がん患者の増加に伴い、革新的な治療オプションに対する需要が高まっています。治療用ワクチンは、従来の治療法に代わる有望な選択肢となります。2010年にFDAによって承認されたProvenge（sipuleucel-T）は、承認を受けてがん治療に処方された最初の治療用がんワクチンです。さらに、腫瘍学、免疫学、遺伝子治療の進歩により、様々ながんや自己免疫疾患に対する治療の選択肢が広がっています。こうした進歩にもかかわらず、処方薬支出は増え続けています。米国医療システム薬剤師協会によると、2024年には米国は処方薬に8,059億米ドルを費やし、前年比10.2％増となります。この増加は、これらの医薬品に対する需要の高まりと、高価な新しい治療法の導入によるものです。さらに、アメリカ人の79％が処方箋薬価は「不合理」であると考えており、70％が処方箋薬価の引き下げをヘルスケアの最優先課題と考えています。ランド・コーポレーションによると、米国の処方箋薬価は、経済協力開発機構（OECD）加盟の他の32カ国の平均の2.56倍で、先発医薬品は3.44倍です。こうしたコストに対処するため、メディケアの薬価交渉を目的としたインフレ削減法（IRA）が導入されました。2024年、米国政府はIRA2022に基づく最初の10品目の薬価を決定し、大きな節目を迎えました。製薬メーカーとの数ヶ月にわたる交渉の結果、ステラーラやジャーディアンスなどの薬価が38％から79％引き下げられました。これらの変更により、2026年までに納税者は60億米ドルを節約し、患者には15億米ドルの節約になると予想されています。

支出は増加の一途をたどっていますが、米国人にとってより手頃な価格で医薬品を購入できるようにするための立法努力が進められています。2025年5月、ドナルド・トランプ大統領は"Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients "と題する大統領令に署名しました。トランプ大統領は、この大統領令の狙いは、アメリカ人と納税者が処方薬に支払う価格を、同等の国で支払われている価格に合わせることだと述べています。この措置により、薬価は少なくとも50％削減される見込みであり、トランプ大統領の2020年最恵国待遇モデルの、より積極的なバージョンとして位置づけられています。

個別化医療と精密医療の成長が今後の市場機会をもたらす

個別化医療と精密医療は、技術的進歩、ゲノミクスへの理解の深まり、個別化された治療アプローチの採用が増加しています。個別化医療は、個人の遺伝的、環境的、ライフスタイル的要因に基づいてヘルスケアをカスタマイズするもので、より効果的で的を絞った治療を可能にします。HER2陽性乳がんに対するトラスツズマブ（ハーセプチン）のような標的がん治療の開発は、遺伝子プロファイリングが特定の治療から最も恩恵を受ける患者を特定し、有効性を向上させ、副作用を軽減することを例証しています。コンパニオン診断薬の採用が進むことで、遺伝子検査が日常臨床に組み込まれ、薬剤の有効性と安全性が高まると予想されます。

人工知能（AI）やビッグデータ解析などの技術の進歩は、個別化医療における発見を加速させています。AI主導のアルゴリズムが膨大なデータセットを分析することで、薬剤に対する個々の反応を予測し、新たな治療標的を特定し、薬剤開発プロセスを合理化します。例えば、Tempusのような企業はAIを活用して、患者の遺伝子プロファイルに基づいてがん治療を調整し、より正確で効果的な介入を提供しています。したがって、技術革新と、より効果的で安全な、患者中心の治療法の臨床採用の増加により、ヘルスケアの提供と転帰が世界的に変革され、今後数年間の市場成長に寄与すると予想されます。

米国食品医薬品局、国立がん研究所、欧州医薬品庁、中央医薬品標準管理機構、Our World in dataなどは、処方薬市場レポート作成時に参照した一次情報および二次情報の一つです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • アナリスト市場の展望

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ
  • 仮定と限界

第4章 処方薬市場の情勢

  • PEST分析

第5章 処方箋薬市場 - 主要市場力学

  • 処方薬市場 - 主な市場力学
  • 市場促進要因
    • 慢性疾患の有病率の増加
    • 革新的かつ特殊な医薬品の開発と採用
  • 市場抑制要因
    • 薬価の高騰と手頃な価格の問題
  • 市場機会
    • 市場企業の戦略的取り組み
  • 今後の動向
    • 個別化医療と精密医療の成長
  • 促進要因と抑制要因の影響

第6章 処方薬市場 - 世界市場分析

  • 処方薬市場の売上高、2021年～2031年
  • 処方薬市場の予測分析

第7章 処方薬市場分析 - 製品タイプ別

  • ブランド医薬品
  • ジェネリック医薬品

第8章 処方薬市場の分析 - 薬剤タイプ別

  • 低分子医薬品
  • 生物製剤とバイオシミラー

第9章 処方薬市場の分析 - 治療領域別

  • がん領域
  • 心血管疾患
  • 神経疾患
  • 代謝性疾患
  • 呼吸器疾患
  • 免疫学
  • その他

第10章 処方薬市場分析 - 投与経路別

  • 経口剤
  • 注射剤
  • 外用薬
  • その他

第11章 処方薬の市場分析 - 流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第12章 処方薬市場分析 - 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州諸国
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他のアジア太平洋諸国
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他の中東とアフリカ諸国
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第13章 競合情勢

  • 主要企業によるヒートマップ分析
  • 企業のポジショニングと集中度

第14章 業界情勢

  • 処方薬市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第15章 企業プロファイル

  • Johnson & Johnson
  • Pfizer Inc
  • Merck & Co Inc
  • Eli Lilly and Co
  • ESTEVE
  • AstraZeneca Plc
  • Sanofi SA
  • GSK Plc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • AbbVie Inc
  • Teva Pharmaceutical Industries Ltd

第16章 付録

図表

List Of Tables

  • Table 1. Prescription Drugs Market Segmentation
  • Table 2. Key Brands Facing Patent Expirations
  • Table 3. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 4. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 5. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 6. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 7. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 8. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 9. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 10. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 11. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 12. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 13. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 14. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 15. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 16. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 17. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 18. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 19. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 20. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 21. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 22. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 23. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 24. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 25. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 26. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 27. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 28. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 29. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 30. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 31. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 32. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 33. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 34. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 35. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 36. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 37. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 38. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 39. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 40. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 41. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 42. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 43. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 44. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 45. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 46. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 47. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 48. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 49. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 50. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 51. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 52. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 53. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 54. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 55. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 56. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 57. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 58. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 59. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 60. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 61. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 62. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 63. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 64. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 65. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 66. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 67. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 68. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 69. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 70. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 71. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 72. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 73. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 74. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 75. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 76. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 77. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 78. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 79. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 80. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 81. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 82. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 83. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 84. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 85. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 86. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 87. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 88. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 89. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 90. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 91. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 92. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 93. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 94. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 95. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 96. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 97. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 98. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 99. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 100. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 101. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 102. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 103. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 104. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 105. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 106. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 107. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 108. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 109. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 110. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 111. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 112. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 113. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 114. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 115. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 116. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 117. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 118. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 119. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 120. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 121. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 122. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 123. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 124. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 125. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 126. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 127. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 128. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 129. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 130. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 131. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 132. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 133. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 134. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 135. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 136. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 137. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 138. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 139. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 140. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 141. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 142. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 143. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 144. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 145. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 146. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 147. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 148. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 149. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 150. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 151. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 152. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 153. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 154. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 155. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 156. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 157. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 158. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 159. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 160. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 161. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 162. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 163. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 164. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 165. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 166. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 167. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 168. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 169. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 170. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 171. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 172. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 173. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 174. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 175. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 176. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 177. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 178. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 179. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 180. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 181. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 182. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 183. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 184. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 185. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 186. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 187. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 188. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 189. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 190. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 191. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 192. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 193. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 194. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 195. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 196. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 197. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 198. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 199. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 200. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 201. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 202. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 203. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 204. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 205. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 206. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 207. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 208. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 209. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 210. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 211. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 212. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 213. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 214. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 215. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 216. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 217. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 218. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 219. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 220. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 221. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 222. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 223. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 224. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 225. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 226. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 227. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 228. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 229. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 230. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 231. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 232. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 233. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 234. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 235. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 236. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 237. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 238. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 239. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 240. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 241. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 242. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 243. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 244. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 245. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 246. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 247. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 248. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 249. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 250. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 251. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 252. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 253. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 254. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 255. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 256. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 257. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 258. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 259. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 260. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 261. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 262. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 263. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
  • Table 264. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
  • Table 265. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
  • Table 266. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
  • Table 267. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
  • Table 268. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
  • Table 269. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
  • Table 270. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
  • Table 271. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
  • Table 272. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
  • Table 273. Heat Map Analysis by Key Players
  • Table 274. Recent Organic Growth Strategies in the Prescription Drugs Market
  • Table 275. Recent Inorganic Growth Strategies in the Prescription Drugs Market
  • Table 276. Glossary of Terms, Medical Cables Market

List Of Figures

  • Figure 1. Prescription Drugs Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Prescription Drugs Market Revenue (US$ Billion), 2021-2031
  • Figure 5. Prescription Drugs Market Revenue (US$ Billion) Forecast Analysis, 2021-2031
  • Figure 6. Prescription Drugs Market Share (%) - by Product Type (2024 and 2031)
  • Figure 7. Branded: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 8. Generics: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 9. Prescription Drugs Market Share (%) - by Drug Type (2024 and 2031)
  • Figure 10. Small Molecule: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 11. Biologics and Biosimilar: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 12. Prescription Drugs Market Share (%) - by Therapeutic Area (2024 and 2031)
  • Figure 13. Oncology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 14. Cardiovascular Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 15. Neurological Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 16. Metabolic Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 17. Respiratory Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 18. Immunology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 19. Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 20. Prescription Drugs Market Share (%) - by Route Of Administration (2024 and 2031)
  • Figure 21. Oral: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 22. Injectable: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 23. Topical: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 24. Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 25. Prescription Drugs Market Share (%) - by Distribution Channel (2024 and 2031)
  • Figure 26. Hospital Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 27. Retail Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 28. Online Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • Figure 29. North America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 30. North America: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 31. United States: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 32. Canada: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 33. Mexico: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 34. Europe: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 35. Europe: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 36. Germany: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 37. United Kingdom: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 38. France: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 39. Italy: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 40. Spain: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 41. Rest of Europe: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 42. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 43. Asia Pacific: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 44. China: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 45. Japan: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 46. India: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 47. Australia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 48. South Korea: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 49. Rest of APAC: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 50. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 51. Middle East and Africa: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 52. Saudi Arabia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 53. South Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 54. United Arab Emirates: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 55. Rest of Middle East and Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 56. South and Central America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
  • Figure 57. South and Central America: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 58. Brazil: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 59. Argentina: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 60. Rest of South and Central America: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
  • Figure 61. Company Positioning & Concentration
  • Figure 62. Growth Strategies in the Prescription Drugs Market
目次
Product Code: TIPRE00040966

According to our new research study on "Prescription Drugs Market Forecast to 2031 -Global Analysis - by Product Type, Drug Type, Route Of Administration, Therapeutic Area, And Distribution Channel," the market is anticipated to grow from US$ 1,440.79 billion in 2024 and is projected to reach US$ 2,350.12 billion by 2031; it is expected to register a CAGR of 7.3% from 2025 to 2031. The prescription drugs market growth is attributed to the increasing prevalence of chronic disorders and development and adoption of innovative and specialty drugs.

Prescription drugs are medications that legally require a medical prescription from a licensed healthcare professional. They are regulated because they can have significant effects on the body, require monitoring for safety, or have potential for misuse.

The prescription drugs market in North America is segmented into the US, Canada, and Mexico. North America is likely to capture a significant share of the global market. One of the primary drivers is the region's aging population. As the baby boomer generation grows older, the prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer has increased, thereby boosting the demand for prescription medications.

Advancements in pharmaceutical research and biotechnology have also played a critical role. Innovations in drug development, including biologics and personalized medicine, have expanded treatment options, enhancing efficacy and safety. The introduction of novel therapies for previously untreatable conditions has further propelled market growth.

Another major contributor is the strong healthcare infrastructure in North America, supported by substantial investments in healthcare facilities, insurance coverage, and pharmaceutical distribution networks. The widespread availability of healthcare services and better patient awareness about disease management have increased prescription drug consumption. Additionally, regulatory support from agencies such as the US Food and Drug Administration (FDA) facilitates quicker approval processes for innovative drugs, enabling faster market entry. Furthermore, government initiatives aimed at expanding healthcare coverage, such as the Affordable Care Act in the US, have increased access to prescription drugs for a broader population.

Also, the rise in lifestyle-related diseases and increased prevalence of mental health disorders have created a sustained demand for therapeutic drugs. The COVID-19 pandemic also emphasized the importance of pharmaceutical interventions, accelerating investments in drug development and distribution.

In North America, the US holds a significant share of the prescription drugs market. Chronic conditions such as cancer, heart disease, and diabetes are contributing to the rising demand for prescription medications. Heart disease remains the leading cause of death in the US, with nearly one million Americans annually succumbing to cardiovascular disease (CVD). According to the American Heart Association, nearly half of all adults in the US have some type of CVD, and it is estimated that the number of adults suffering from heart failure is projected to increase by 2035. Over 130 million adults, i.e., 45.1% of the US population, are expected to report some form of CVD by 2035. This surge in CVD cases leads to a higher number of patients requiring long-term medication management, including statins, beta-blockers, anticoagulants, and antihypertensive drugs.

According to the American Cancer Society, in 2022, ~1.9 million new cases of cancer were diagnosed in the country, and it caused ~0.61 million deaths. With the increasing cases of cancer, the demand for innovative treatment options is rising. Therapeutic vaccines offer promising alternatives to traditional therapies. Provenge (sipuleucel-T), approved by the FDA in 2010, is the first therapeutic cancer vaccine to receive approval and prescribed medication for cancer treatment. Additionally, advancements in oncology, immunology, and gene therapies are expanding treatment options for various cancers and autoimmune diseases. Despite these advancements, prescription drug spending continues to rise. According to the American Society of Health-System Pharmacists, in 2024, Americans spent US$ 805.9 billion on prescription drugs, a 10.2% increase from the previous year. This increase is attributed to higher demand for these medications and the introduction of new, expensive treatments. Additionally, 79% of Americans believe that prescription drug prices are "unreasonable," while 70% consider reducing these costs to be their top healthcare priority. According to the Rand Corporation, on average, prescription drug prices in the US are 2.56 times higher than those in 32 other Organization for Economic Co-operation and Development (OECD) countries, with brand-name medications costing 3.44 times more. To address these costs, the Inflation Reduction Act (IRA), which aims to negotiate drug prices for Medicare, was introduced. In 2024, the US government finalized prices for the first ten drugs under the IRA 2022, marking a significant milestone. After months of negotiations with drug manufacturers, prices for medications such as Stelara and Jardiance have reduced by 38% to 79%. These changes are anticipated to save taxpayers US$6 billion by 2026 and provide US$1.5 billion in savings for patients.

While spending continues to rise, legislative efforts are underway to make medications more affordable for Americans. In May 2025, President Donald Trump signed an executive order titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients." Trump stated that the order aims to align the prices Americans and taxpayers pay for prescription drugs with those paid in comparable countries. The measure is expected to cut drug prices by at least 50% and is characterized as a more aggressive version of Trump's 2020 Most Favored Nation model.

Growth of Personalized and Precision Medicine to Provide Market Opportunities in Future

Personalized and precision medicine is experiencing growing technological advancements, increasing understanding of genomics, and rising adoption of personalized therapeutic approaches. Personalized medicine involves customizing healthcare based on individual genetic, environmental, and lifestyle factors, allowing for more effective and targeted treatments. The development of targeted cancer therapies such as trastuzumab (Herceptin) for HER2-positive breast cancer exemplifies how genetic profiling can identify patients who will benefit most from specific treatments, improving efficacy and reducing adverse effects. The increasing adoption of companion diagnostics is expected to integrate genetic testing into routine clinical practice, enhancing drug efficacy and safety.

Technological advancements such as artificial intelligence (AI) and big data analytics are accelerating discoveries in personalized medicine. AI-driven algorithms analyze vast datasets to predict individual responses to drugs, identify new therapeutic targets, and streamline drug development processes. For instance, companies such as Tempus are harnessing AI to tailor cancer treatments based on patients' genetic profiles, offering more precise and effective interventions. Therefore, technological innovations and increasing clinical adoption of more effective, safer, and patient-centric therapies, transforming healthcare delivery and outcomes globally, are expected to contribute to the market growth in coming years.

The US Food and Drug Administration, National Cancer Institute, European Medicines Agency, Central Drugs Standard Control Organization, and Our World in data are among the primary and secondary sources referred to while preparing the prescription drugs market report.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Prescription Drugs Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Prescription Drugs Market - Key Market Dynamics

  • 5.1 Prescription Drugs Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Increasing Prevalence of Chronic Disorders
    • 5.2.2 Development and Adoption of Innovative and Specialty Drugs
  • 5.3 Market Restraints
    • 5.3.1 High Drug Prices and Affordability Issues
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Growth of Personalized and Precision Medicine
  • 5.6 Impact of Drivers and Restraints:

6. Prescription Drugs Market - Global Market Analysis

  • 6.1 Prescription Drugs Market Revenue (US$ Billion), 2021-2031
  • 6.2 Prescription Drugs Market Forecast Analysis

7. Prescription Drugs Market Analysis - by Product Type

  • 7.1 Branded
    • 7.1.1 Overview
    • 7.1.2 Branded: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 7.2 Generics
    • 7.2.1 Overview
    • 7.2.2 Generics: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

8. Prescription Drugs Market Analysis - by Drug Type

  • 8.1 Small Molecule
    • 8.1.1 Overview
    • 8.1.2 Small Molecule: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 8.2 Biologics and Biosimilar
    • 8.2.1 Overview
    • 8.2.2 Biologics and Biosimilar: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

9. Prescription Drugs Market Analysis - by Therapeutic Area

  • 9.1 Oncology
    • 9.1.1 Overview
    • 9.1.2 Oncology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.2 Cardiovascular Diseases
    • 9.2.1 Overview
    • 9.2.2 Cardiovascular Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.3 Neurological Diseases
    • 9.3.1 Overview
    • 9.3.2 Neurological Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.4 Metabolic Diseases
    • 9.4.1 Overview
    • 9.4.2 Metabolic Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.5 Respiratory Diseases
    • 9.5.1 Overview
    • 9.5.2 Respiratory Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.6 Immunology
    • 9.6.1 Overview
    • 9.6.2 Immunology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

10. Prescription Drugs Market Analysis - by Route Of Administration

  • 10.1 Oral
    • 10.1.1 Overview
    • 10.1.2 Oral: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 10.2 Injectable
    • 10.2.1 Overview
    • 10.2.2 Injectable: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 10.3 Topical
    • 10.3.1 Overview
    • 10.3.2 Topical: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

11. Prescription Drugs Market Analysis - by Distribution Channel

  • 11.1 Hospital Pharmacies
    • 11.1.1 Overview
    • 11.1.2 Hospital Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 11.2 Retail Pharmacies
    • 11.2.1 Overview
    • 11.2.2 Retail Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
  • 11.3 Online Pharmacies
    • 11.3.1 Overview
    • 11.3.2 Online Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)

12. Prescription Drugs Market - Geographical Analysis

  • 12.1 North America
    • 12.1.1 North America Prescription Drugs Market Overview
    • 12.1.2 North America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.1.2.1 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.1.2.2 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.1.2.3 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.1.2.4 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.1.2.5 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.1.3 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.1.3.1 United States: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.1.3.1.1 United States: Prescription Drugs Market Breakdown, by Product Type
        • 12.1.3.1.2 United States: Prescription Drugs Market Breakdown, by Drug Type
        • 12.1.3.1.3 United States: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.1.3.1.4 United States: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.1.3.1.5 United States: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.1.3.2 Canada: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.1.3.2.1 Canada: Prescription Drugs Market Breakdown, by Product Type
        • 12.1.3.2.2 Canada: Prescription Drugs Market Breakdown, by Drug Type
        • 12.1.3.2.3 Canada: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.1.3.2.4 Canada: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.1.3.2.5 Canada: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.1.3.3 Mexico: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.1.3.3.1 Mexico: Prescription Drugs Market Breakdown, by Product Type
        • 12.1.3.3.2 Mexico: Prescription Drugs Market Breakdown, by Drug Type
        • 12.1.3.3.3 Mexico: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.1.3.3.4 Mexico: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.1.3.3.5 Mexico: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.2 Europe
    • 12.2.1 Europe Prescription Drugs Market Overview
    • 12.2.2 Europe: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.2.2.1 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.2.2.2 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.2.2.3 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.2.2.4 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.2.2.5 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.2.3 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.2.3.1 Germany: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.1.1 Germany: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.1.2 Germany: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.1.3 Germany: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.1.4 Germany: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.1.5 Germany: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.2 United Kingdom: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.2.1 United Kingdom: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.2.2 United Kingdom: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.2.3 United Kingdom: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.2.4 United Kingdom: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.2.5 United Kingdom: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.3 France: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.3.1 France: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.3.2 France: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.3.3 France: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.3.4 France: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.3.5 France: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.4 Italy: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.4.1 Italy: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.4.2 Italy: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.4.3 Italy: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.4.4 Italy: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.4.5 Italy: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.5 Spain: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.5.1 Spain: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.5.2 Spain: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.5.3 Spain: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.5.4 Spain: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.5.5 Spain: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.2.3.6 Rest of Europe: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.2.3.6.1 Rest of Europe: Prescription Drugs Market Breakdown, by Product Type
        • 12.2.3.6.2 Rest of Europe: Prescription Drugs Market Breakdown, by Drug Type
        • 12.2.3.6.3 Rest of Europe: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.2.3.6.4 Rest of Europe: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.2.3.6.5 Rest of Europe: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.3 Asia Pacific
    • 12.3.1 Asia Pacific Prescription Drugs Market Overview
    • 12.3.2 Asia Pacific: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.3.2.1 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.3.2.2 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.3.2.3 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.3.2.4 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.3.2.5 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.3.3 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.3.3.1 China: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.1.1 China: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.1.2 China: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.1.3 China: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.1.4 China: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.1.5 China: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.2 Japan: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.2.1 Japan: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.2.2 Japan: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.2.3 Japan: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.2.4 Japan: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.2.5 Japan: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.3 India: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.3.1 India: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.3.2 India: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.3.3 India: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.3.4 India: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.3.5 India: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.4 Australia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.4.1 Australia: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.4.2 Australia: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.4.3 Australia: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.4.4 Australia: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.4.5 Australia: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.5 South Korea: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.5.1 South Korea: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.5.2 South Korea: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.5.3 South Korea: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.5.4 South Korea: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.5.5 South Korea: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.3.3.6 Rest of APAC: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.3.3.6.1 Rest of APAC: Prescription Drugs Market Breakdown, by Product Type
        • 12.3.3.6.2 Rest of APAC: Prescription Drugs Market Breakdown, by Drug Type
        • 12.3.3.6.3 Rest of APAC: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.3.3.6.4 Rest of APAC: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.3.3.6.5 Rest of APAC: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.4 Middle East and Africa
    • 12.4.1 Middle East and Africa Prescription Drugs Market Overview
    • 12.4.2 Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.4.2.1 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.4.2.2 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.4.2.3 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.4.2.4 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.4.2.5 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.4.3 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.4.3.1 Saudi Arabia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.1.1 Saudi Arabia: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.1.2 Saudi Arabia: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.1.3 Saudi Arabia: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.1.4 Saudi Arabia: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.1.5 Saudi Arabia: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.4.3.2 South Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.2.1 South Africa: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.2.2 South Africa: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.2.3 South Africa: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.2.4 South Africa: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.2.5 South Africa: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.4.3.3 United Arab Emirates: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.3.1 United Arab Emirates: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.3.2 United Arab Emirates: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.3.3 United Arab Emirates: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.3.4 United Arab Emirates: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.3.5 United Arab Emirates: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.4.3.4 Rest of Middle East and Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.4.3.4.1 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Product Type
        • 12.4.3.4.2 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Drug Type
        • 12.4.3.4.3 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.4.3.4.4 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.4.3.4.5 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Distribution Channel
  • 12.5 South and Central America
    • 12.5.1 South and Central America Prescription Drugs Market Overview
    • 12.5.2 South and Central America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
      • 12.5.2.1 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
      • 12.5.2.2 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
      • 12.5.2.3 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
      • 12.5.2.4 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
      • 12.5.2.5 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
    • 12.5.3 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.5.3.1 Brazil: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.5.3.1.1 Brazil: Prescription Drugs Market Breakdown, by Product Type
        • 12.5.3.1.2 Brazil: Prescription Drugs Market Breakdown, by Drug Type
        • 12.5.3.1.3 Brazil: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.5.3.1.4 Brazil: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.5.3.1.5 Brazil: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.5.3.2 Argentina: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.5.3.2.1 Argentina: Prescription Drugs Market Breakdown, by Product Type
        • 12.5.3.2.2 Argentina: Prescription Drugs Market Breakdown, by Drug Type
        • 12.5.3.2.3 Argentina: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.5.3.2.4 Argentina: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.5.3.2.5 Argentina: Prescription Drugs Market Breakdown, by Distribution Channel
      • 12.5.3.3 Rest of South and Central America: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
        • 12.5.3.3.1 Rest of South and Central America: Prescription Drugs Market Breakdown, by Product Type
        • 12.5.3.3.2 Rest of South and Central America: Prescription Drugs Market Breakdown, by Drug Type
        • 12.5.3.3.3 Rest of South and Central America: Prescription Drugs Market Breakdown, by Therapeutic Area
        • 12.5.3.3.4 Rest of South and Central America: Prescription Drugs Market Breakdown, by Route Of Administration
        • 12.5.3.3.5 Rest of South and Central America: Prescription Drugs Market Breakdown, by Distribution Channel

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning & Concentration

14. Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Prescription Drugs Market
  • 14.3 Organic Growth Strategies
    • 14.3.1 Overview
  • 14.4 Inorganic Growth Strategies
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Johnson & Johnson
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Pfizer Inc
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Merck & Co Inc
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Eli Lilly and Co
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 ESTEVE
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 AstraZeneca Plc
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Sanofi SA
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 GSK Plc
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 F. Hoffmann-La Roche Ltd
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Novartis AG
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments
  • 15.11 AbbVie Inc
    • 15.11.1 Key Facts
    • 15.11.2 Business Description
    • 15.11.3 Products and Services
    • 15.11.4 Financial Overview
    • 15.11.5 SWOT Analysis
    • 15.11.6 Key Developments
  • 15.12 Teva Pharmaceutical Industries Ltd
    • 15.12.1 Key Facts
    • 15.12.2 Business Description
    • 15.12.3 Products and Services
    • 15.12.4 Financial Overview
    • 15.12.5 SWOT Analysis
    • 15.12.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms